Update
The IMS Recommendations on Midlife Women’s Health are currently being reviewed and updated and will be published in the IMS peer-reviewed Journal, Climacteric, during 2025.
2016 IMS RECOMMENDATIONS ON WOMENS MIDLIFE HEALTH AND MENOPAUSE HORMONE THERAPY
April 2016
Climacteric 2016;19:109-150
UPDATED 2013 IMS RECOMMENDATIONS ON MENOPAUSAL HORMONE THERAPY AND PREVENTIVE STRATEGIES FOR MIDLIFE HEALTH
June 2013
Climacteric 2013;16:316-337
UPDATED IMS RECOMMENDATIONS ON POSTMENOPAUSAL HORMONE THERAPY AND PREVENTIVE STRATEGIES FOR MIDLIFE HEALTH
June 2011
Climacteric 2011;14:302–320
RECOMMENDATIONS FOR THE MANAGEMENT OF POSTMENOPAUSAL VAGINAL ATROPHY
October 2010
Climacteric 2010; Early Online, 1–14
ASSESMENT AND MANAGEMENT OF CARDIOVASCULAR RISKS IN WOMEN
A Short Guide for Menopause Physicians
June 2007
IMS UPDATED RECOMMENDATIONS ON POSTMENOPAUSAL HORMONE THERAPY
February 2007
Climacteric 2007; 10:181–94
GUIDELINES FOR HORMONE TREATMENT OF WOMEN IN THE MENOPAUSAL TRANSITION AND BEYOND – POSITION STATEMENT BY THE EXECUTIVE COMMITTEE OF THE INTERNATIONAL MENOPAUSE SOCIETY (REVISED)
October 2004
Climacteric 2004; 7:333–7 Revised October 15, 2004
GUIDELINES FOR THE HORMONE THERAPY OF WOMEN IN THE MENOPAUSAL TRANSITION AND BEYOND
February 2004
Climacteric 2004; 7:8–11 February 13, 2004
